Identifying Epistasis in Cancer Genomes: A Delicate Affair

Cell. 2019 May 30;177(6):1375-1383. doi: 10.1016/j.cell.2019.05.005.


Recent studies of the tumor genome seek to identify cancer pathways as groups of genes in which mutations are epistatic with one another or, specifically, "mutually exclusive." Here, we show that most mutations are mutually exclusive not due to pathway structure but to interactions with disease subtype and tumor mutation load. In particular, many cancer driver genes are mutated preferentially in tumors with few mutations overall, causing mutations in these cancer genes to appear mutually exclusive with numerous others. Researchers should view current epistasis maps with caution until we better understand the multiple cause-and-effect relationships among factors such as tumor subtype, positive selection for mutations, and gross tumor characteristics including mutational signatures and load.

Keywords: cancer; cancer genome; co-occurrence; epistasis; genome; mutation; mutation load; mutual exclusivity; subtype; systems biology.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Algorithms
  • Computational Biology / methods
  • Epistasis, Genetic / genetics*
  • Epistasis, Genetic / physiology
  • Genes, Neoplasm / genetics*
  • Genes, Neoplasm / physiology
  • Humans
  • Models, Genetic
  • Mutation / genetics
  • Neoplasms / genetics*
  • Oncogenes / genetics